Sight’s mission is to improve health by providing fast, accurate, and pain-free testing when and where it is needed. Sight has created a ground-breaking method to digitize blood: combining digital microscopy with AI. This method was first deployed in 2014 through Parasight, a malaria detection device sold in 25 countries. In 2018, Sight launched OLO, the world’s first lab-grade Complete Blood Count analyzer for point-of-care. In the future, Sight will apply its method to further applications.